Related Experiment Videos
An in-vivo-in-vitro correlation for the bioavailability of frusemide tablets
The Journal of Pharmacy and Pharmacology
|August 1, 1984
Summary
Investigating frusemide tablet dissolution revealed a linear correlation between 30-minute dissolution rates and in vivo bioavailability. This dissolution testing accurately predicts frusemide bioavailability, aiding formulation development.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery and Formulation
Background:
- Frusemide is a critical diuretic medication.
- Assessing oral drug bioavailability is essential for therapeutic efficacy.
- Dissolution testing serves as a surrogate for in vivo performance.
Purpose of the Study:
- To evaluate the dissolution behavior of various frusemide tablet formulations.
- To establish a correlation between in vitro dissolution and in vivo bioavailability of frusemide.
- To validate dissolution testing as a predictive tool for frusemide oral absorption.
Main Methods:
- Utilized the USP rotating basket apparatus for dissolution testing.
- Employed pH 5.0 buffer at 37°C as the dissolution medium.
- Compared dissolution profiles of four commercial and two experimental frusemide tablet formulations.
Main Results:
- A significant linear relationship was observed between the percentage of frusemide dissolved in 30 minutes and its relative bioavailability.
- The observed bioavailability range was 76-97% relative to an oral solution.
- Predicted bioavailability values showed a maximum deviation of only 2% from measured values.
Conclusions:
- In vitro dissolution testing of frusemide tablets effectively predicts in vivo bioavailability.
- The established linear correlation supports the use of dissolution profiles for quality control and formulation optimization.
- This predictive model enhances the development of bioequivalent frusemide formulations.